Food trucks are hitting the streets from Miami to Maui but greasy reheated tacos and soggy burgers are a thing of the past. Today's mobile eateries have foodies flocking for gourmet bacon jam burgers, delicious Parisian-style crepes, and decadent handcrafted organic ice cream cones just to name a few. A less expensive alternative to opening a brick-and-mortar restaurant, food trucks, food trailers, food carts, and even food bicycles can be started by anyone whether you're a trained chef or an amateur baker. If you've ever dreamed of jumping on the food truck bandwagon this book will provide you with all the information necessary to get you on the road. Highlights include: * Understanding all the startup costs and sources for purchasing or leasing your kitchen on wheels; * Building a business plan that will guide decision making and set you up for success; * Scouting locations for optimal visability and sales; * Calculating your true product costs and how to price your menu in a way that will be profitable; * Connecting with customers inexpensively by using traditional marketing tools and social media to keep them coming back for more; and * Appendices containing detailed worksheets that clearly walk you through the financial side of the business and comprehensive lists of resources and business licensing offices broken down by state and territory.

“ Blood Feud rivals A Civil Action for best non-fiction book of the past twenty years.” — John Lescroart, New York Times bestselling author of Damage Procrit seemed like a biotech miracle, promising a golden age in medical care. Developed in the 1980s by Amgen and licensed to the pharmaceutical giant, Johnson & Johnson, the drug (AKA Epogen and Aranesp) soon generated billions in annual revenue—and still does. In 2012, world famous cyclist, Olympian, and Tour de France champion Lance Armstrong was banned from professional cycling on doping charges for using EPO (the blanket name for the drugs Procrit and Epogen), resulting in a global controversy about abuse, big pharmaceutical companies, and the lies and inaccuracies concerning performance-enhancing drugs. Mark Duxbury was a J&J salesman who once believed in the blood-booster, setting record sales and winning company awards. Then Duxbury started to learn unsavory truths about Procrit and J&J’s business practices. He was fired and filed a whistleblower suit to warn the public. When Jan Schlichtman ( A Civil Action ) learned of Duxbury’s crusade, he signed on. Now, he’s fighting on behalf of cancer patients and for every American who trusts Big Pharma with his life.